The UK medical cannabis conversations that mattered most for 2025 (so far)
9 min read
Sam North
What mattered most for UK medical cannabis patients in 2025? In this midyear review, we spotlight one Releaf blog per month, covering legality, absorption, stigma, stop and search, and more. Each post is written to inform and empower patients navigating a changing clinical and legal landscape.
Contents
Why patient education is more vital than ever
At Releaf, we don’t treat blogs as filler. Every single Releaf blog we publish (and we publish one Monday to Friday - rain, hail, or shine) is the result of careful research, patient-first intention, and clinical review.
Whether we’re decoding medical cannabis research papers into more accessible language, covering all breaking industry news stories both here and globally, focusing on specific conditions and how medical cannabis treatment may help, or unpacking the finer points of UK medical cannabis law, our goal is always the same: to offer not just Releaf patients, but the entirety of the UK (and beyond), a space where they can find a new blog - accurate, useful, and relevant medical cannabis information - every week day.
But with 2025 now hitting the halfway point, we thought it was the right moment to pause, look back, and spotlight one key article from each month so far. From legality to tolerance breaks, fasting to decriminalisation, this isn’t just a promo piece tooting our own proverbial horn, but more of a reflection of what we think matters most to UK patients right now.
January: What is and isn’t legal for medical cannabis patients in the UK
This article lays out what UK medical cannabis patients are legally allowed to do, and where the limits still lie. It answers the most common questions around prescriptions, formulations, travel, and patient rights in public, at work, and behind the wheel. This one is essential reading for anyone interested in how medical cannabis works in the UK.
- Who can prescribe: Only specialist doctors listed on the General Medical Council’s specialist register (not your GP) are legally allowed to initiate medical cannabis prescriptions in the UK. At Releaf, we have a world-class clinical team led by our Medical Director, Dr. Sue Clenton, a specialist in oncological care. This team includes 27+ doctors with expertise in chronic pain treatment, neurology, psychiatry, gastroenterology, general practice, and beyond.
- UK medical cannabis eligibility: UK residents with a chronic or treatment-resistant condition who have tried at least two conventional treatments without success may be potentially eligible for a medical cannabis prescription through Releaf. You can check your suitability in less than 20 seconds with our fast and free medical cannabis eligibility checker.
- Common conditions: Medical cannabis can be legally prescribed in the UK for a surprisingly wide range of health concerns, including chronic pain conditions like arthritis and endometriosis, cancer treatment issues, gastrointestinal conditions like IBS or Crohn’s, neurological conditions like epilepsy and ADHD, and mental health concerns such as depression, PTSD, or anxiety. But it's always based on your individual case, health needs, and medical history.
- Permitted formats: With a Releaf prescription, you have access to a wide range of medical cannabis flower and medical cannabis oil options. We also recently introduced THC vapes into our formulary.
- Public use: Like any prescribed medication, you’re allowed to carry and use medical cannabis in public. It must stay in its original packaging, and it’s important to carry proof of your prescription at all times. All Releaf patients receive a free Medical Cannabis Card, to help if you are ever questioned about current prescription and legal status as a prescribed UK medical cannabis patient. If you need to medicate on the go, it’s best to stay discreet and avoid enclosed or crowded areas.
- Travel: Travelling within the UK is fine. Going abroad is another story. You’ll need approval from the destination country’s embassy, and ideally a letter from your doctor too. Never assume that a UK prescription makes you legally covered elsewhere.
- Driving: You can legally drive after medicating with your prescribed cannabis, but only if you’re not impaired. It is always best to err on the side of caution - if you feel any mental fogginess or fatigue, find an alternative travel option.
- Workplace rights: If your condition qualifies as a disability, your employer may be required to make reasonable adjustments. But it is your responsibility to let them know if your medication timing could affect your ability to do the job in a fully safe manner.
February: Fasting and your prescription — what patients need to know
In this blog, we unpacked how fasting affects cannabinoid absorption, why food (or the lack of it) matters, and what patients should consider when planning their doses.
Intermittent fasting has hit centre stage in the past few years. But while most discussions focus on weight, blood sugar, or longevity, few mention what it means for people taking prescription medicine, including medical cannabis. An empty stomach doesn’t just speed things up, it can also intensify how the effects are felt. That might help with symptom relief, or it might catch you off guard if you’re not expecting it.
We also touched on Ramadan, offering practical advice for those balancing cultural commitments with clinical needs.
March: Redefining the way that legal medical cannabis is marketed in the UK
This blog wasn’t just a branding exercise. It was an explanation of how we are truly invested in getting medical cannabis marketing right.
In March, we shared the thinking behind Releaf’s visual identity: clear language, calm design, and a tone that respects the intelligence and vulnerability of patients.
Why?
Because stigma doesn’t just live in the law. It continues to linger in the consciousness of the UK general public - and this stigma is, unfortunately, sometimes bolstered by the decisions made by industry players.
Here we offered a rare behind-the-scenes look at how Releaf’s brand was built to foster trust (and comply with all regulations), from prescription through to patient support, and how (and why) we choose our words.
For many patients, their journey with cannabis medicine begins on our homepage. It’s our job to make that first impression safe, serious, and legitimate.
April: A patient-friendly guide to cannabis tolerance breaks
This April blog walked readers through the logic and science of tolerance breaks: what they are, why they matter, and how to take one safely.
Tolerance is a simple reality, not a sign of clinical failure. Over time, the body may respond less to the same dose of cannabinoids, which can reduce effectiveness (and potentially raise patient costs).
We focused on medical patients, not recreational users, offering calm, evidence-led advice on timing, symptom tracking, and tapering under clinical supervision. Many of our patients find that a short break, handled correctly, can restore treatment responsiveness.
We also addressed side effects like sleep disturbance and appetite changes, and how to manage these with medical support.
May: Police guidance finally shifts: Smell alone isn’t a reason to stop you
For years, the smell of cannabis has been treated as cause enough to stop and search someone - but no longer. Our highlighted May blog explained the new police guidance that shifts that assumption.
For medical cannabis patients, this change is huge. It reduces the likelihood of public embarrassment, misplaced suspicion, or worse.
The blog explained what this shift means in real life situations, how to protect yourself with clear documentation, and why carrying your legally prescribed medical cannabis in the legally required way is still essential.
We also revisited the importance of Releaf’s Medical Cannabis Card, which can help patients verify their prescription instantly via QR code. Legal progress in the UK has been slow, but each shift matters.
June: What Sadiq Khan’s decriminalisation trial means for patients
June brought more legal headlines, along with a few questions. Sadiq Khan’s support for recreational cannabis decriminalisation raised hopes for more compassionate policing and policy.
But what would it mean for medical patients?
In this blog, we traced the historical context, from the over-policing of minority communities to today’s proposals for change. We also laid out what decriminalisation is (and isn’t), and how public perception affects day-to-day life for legal cannabis users.
Even if the law stays the same, shifts in attitude can have a profound impact on the indentured stigma that still exists, and on patients’ confidence, freedom, and consistency in managing symptoms.
Final thoughts
The medical cannabis landscape in the UK is in a constant state of flux. Policies shift, news hits, and fascinating research is released with every passing month. Staying informed has never mattered more.
Whether you're here for legal clarity, treatment insight, or a better understanding of how your medication works, our blog is designed to meet you there. Every post is researched, written, and reviewed with one goal in mind: helping patients feel more confident in their treatment choices, whether that includes medical cannabis or not.
So stay on top of the Releaf blog, and while you're there, check your medical cannabis eligibility for free in less than 20 seconds.
Share article
Did you like this article?
It is important to seek medical advice before starting any new treatments. The patient advisors at Releaf are available to provide expert advice and support. Alternatively, click here to book a consultation with one of our specialist doctors.
Elevate your wellness with medical cannabis
Get comprehensive care, convenience, and confidence with an all-in-one treatment plan.
Am I eligible?Authors
Sam North, a seasoned writer with over five years' experience and expertise in medicinal cannabis, brings clarity to complex concepts, focusing on education and informed use.
Editorial Policy
All of our articles are written by medical cannabis experts, guided by strict sourcing guidelines, and reference peer-reviewed studies and credible academic research. Our expert clinical team and compliance specialists provide valuable insights to ensure accuracy when required. Learn more in our editorial policy.
Need more help?